Evaluation of the urethral catheter related symptoms administering Lidocaine via the catheter.

Evaluation of the urethral catheter related symptoms administering Lidocaine via the catheter. - Evaluation of the urethral catheter related symptoms administering Lidocaine via the catheter.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018153

Enrollment

Registered

2015-07-01

Start date

2015-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients planned with general anesthesia

Interventions

Lidocaine administration Saline administration

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with Urethral catheter(14F). Patients with ASA-PS 1 or 2. Patients with catheter symptoms 3/5 or more, 30 minutes after surgery.

Exclusion criteria

Exclusion criteria: 1) An urethral patient operated on. 2) It is a patient with a history of the past of hypersensitivity for a Xylocaine or amide type local anesthetic. 3) A patient accepted arrhythmia in an electrocardiogram or the patient who is taking antiarrhythmic. 4) The patient whom it is not got the evaluation that disturbance of consciousness or mutual understanding is difficult, and is fair from. 5) The patient whom it was judged the judgment of the doctor to be inappropriate as an object

Design outcomes

Primary

Measure	Time frame
Change of the catheter related symptoms	—

Secondary

Measure	Time frame
Change of the catheter related symptoms	—

Countries

Japan

Contacts

Public ContactTomonobu Sato

Gunma University Hospital Department of anethesiology

m14702011@gunma-u.ac.jp027-220-8454

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026